Validation Compliance Annual: 1995"Offers an overview of validation and the current regulatory climate and provides a compendium of the regulations, guidance documents, issues, compliance tools, terminology, and literature involved in computer systems validation. Thoroughly examines regulations issued by the U.S. Food and Drug Administration, the U.S. Environmental Protection Agency, and the European Union. Furnishes case studies of real-world situations." |
From inside the book
Results 1-5 of 81
Page
... 324 334 346 • • 408 438 451 in System Validation Chapter 11 Data Integrity and Security Chapter 12 Documentation : The SOP Chapter 13 Electronic Signatures 468 Chapter 14 Drug Inspections 509 Chapter 15 Biologics Inspections 647 V.
... 324 334 346 • • 408 438 451 in System Validation Chapter 11 Data Integrity and Security Chapter 12 Documentation : The SOP Chapter 13 Electronic Signatures 468 Chapter 14 Drug Inspections 509 Chapter 15 Biologics Inspections 647 V.
Page 3
Sorry, this page's content is restricted.
Sorry, this page's content is restricted.
Page 56
Sorry, this page's content is restricted.
Sorry, this page's content is restricted.
Page 83
Sorry, this page's content is restricted.
Sorry, this page's content is restricted.
Page 84
Sorry, this page's content is restricted.
Sorry, this page's content is restricted.
Common terms and phrases
abbreviated application abbreviated new drug adequate agency and/or antibiotic application or abbreviated appropriate approved audit automated data collection batch batch production biological blood bank blood components blood establishments CBER CE marking CGMP clinical investigation compliance computer system computerized conducted contain copy data collection system determine documentation donor Drug Administration drug application drug product effectiveness electronic signatures ensure equipment evaluation finished device firm Food and Drug functions guidelines hardware identified inspection institutional review board intended investigational new drug issues labeling laboratory licensed listed drug maintained manufacturing practice marketing medical devices ment methods notified body paragraph performed person personnel Plasma Plasmapheresis protocol quality assurance quality system reference regulations regulatory request requirements responsible safety samples specifications sponsor sterile storage submitted Subpart substance test systems tion verify